Nello Mainolfi, Chief Executive Officer at Kymera Therapeutics, Inc. (KYMR), sold 94,315 shares at $59.28 ($5.3M) on 2021-10-08, disclosed to the SEC on 2021-10-12.
Open-market sale of $5.3M KYMR by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.56 | 21,236 | $1.2M | 22.2% |
| 2 | $55.56 | 21,236 | $1.2M | 22.2% |
| 3 | $56.82 | 9,369 | $532K | 10.0% |
| 4 | $56.82 | 9,369 | $532K | 10.0% |
| 5 | $57.29 | 2,078 | $119K | 2.2% |
| 6 | $57.29 | 2,078 |
| $119K |
| 2.2% |
| 7 | $59.28 | 7,920 | $469K | 8.8% |
| 8 | $59.28 | 7,920 | $469K | 8.8% |
| 9 | $60.32 | 670 | $40K | 0.8% |
| 10 | $61.87 | 271 | $17K | 0.3% |
| 11 | $53.58 | 5,712 | $306K | 5.8% |
| 12 | $53.58 | 5,712 | $306K | 5.8% |
| 13 | $54.50 | 744 | $41K | 0.8% |
| Total | $56.32 avg | 94,315 | $5.3M | 100% |
| Filing → |
| KYMR | SELL | 2026-07-02 | $9.2M | — | Filing → |
| KYMR | SELL | 2026-04-29 | $2.4M | — | Filing → |
| KYMR | SELL | 2026-02-25 | $2.7M | — | Filing → |